Kinnate Biopharma Stock Forecast - Market Facilitation Index

KNTEDelisted Stock  USD 2.96  0.27  8.36%   
Kinnate Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kinnate Biopharma stock prices and determine the direction of Kinnate Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kinnate Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
Kinnate Biopharma has current Market Facilitation Index of 0.3. Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume.
Check Kinnate Biopharma VolatilityBacktest Kinnate BiopharmaInformation Ratio  

Kinnate Biopharma Trading Date Momentum

On December 28 2024 Kinnate Biopharma was traded for  2.96  at the closing time. The top price for the day was 3.25  and the lowest listed price was  2.95 . There was no trading activity during the period 0.0. Lack of trading volume on December 28, 2024 did not cause price change. The trading delta at closing time against the current closing price is 9.12% .
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare Kinnate Biopharma to competition

View Kinnate Biopharma Related Equities

 Risk & Return  Correlation

Kinnate Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Kinnate Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kinnate Biopharma shares will generate the highest return on investment. By undertsting and applying Kinnate Biopharma stock market strength indicators, traders can identify Kinnate Biopharma entry and exit signals to maximize returns.

Kinnate Biopharma Risk Indicators

The analysis of Kinnate Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kinnate Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kinnate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Kinnate Stock

If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio